Oxidative stress in INS1E and alphaTC1 cells in 3D aggregates. by Mireille M. J. P. E. Sthijns (12245491)

“…B) Seeding INS1E and alphaTC1 cells in the ratios 100:0 and 50:50 in 3D aggregates exposed to 500 μM H₂O₂ decreased the percentage of oxidative stress–positive INS1E cells. …”

Sequential spikes are initiated at the soma when input intensity increases. by Na Chen (153323)

Integrin TMC β-subunits potentially cause integrin clustering and focal adhesion growth through binding with the cytoskeleton. by Mehrdad Mehrbod (342720)

Effects of treatment with mTORC1 blocker rapamycin on taste cells. by Shingo Takai (7853843)

“…<p>(A, B) Confocal images of taste organoids at day 20, cultured in conditioned medium (CM) with 20 ng/ml rapamycin plus 50 nM insulin (A) or 0 nM insulin (B). …”

Short-Term Effects of Experimental Warming and Precipitation Manipulation on Soil Microbial Biomass C and N, Community Substrate Utilization Patterns and Community Composition by LI, Guanlin

“…Decreased and increased precipitation significantly reduced microbial biomass C by 13.5% and 24.9% and microbial biomass N by 22.9% and 17.6% in unwarmed plots, respectively (P < 0.01). …”
Get full text
Get full text

Source Data file.xlsx by Chan Lu (19963167)

“…We found that co-exposure to high temperature and NO₂ elevated blood glucose levels and exacerbated histopathological changes. …”

Rapid Suppression of Activated Rac1 by Cadherins and Nectins during <em>De Novo</em> Cell-Cell Adhesion by Khameeka N. Kitt (227731)

“…Upon initiation of cell-cell contact in 3-D cell aggregates, we observed an initial peak of Rac1 activity that rapidly decreased by ∼66% within 5 minutes, and further decreased to a low baseline level after 30 minutes. …”

Methylation of <em>Wnt7a</em> Is Modulated by DNMT1 and Cigarette Smoke Condensate in Non-Small Cell Lung Cancer by Meredith A. Tennis (179612)

“…The <em>Wnt7a</em> promoter has a higher percentage of methylation in NSCLC tumor tissue compared to matched normal lung tissue and methylation of the promoter region leads to decreased activity. We treated H157 and H1299 NSCLC cell lines with 5-Aza-2′-deoxycytidine and detected loss of <em>Wnt7a</em> promoter methylation, increased Wnt7a expression, and increased activity of the Wnt7a lung signaling pathway. …”

Graphic representation of the cognitive map of France as reflected by gaze positions for the subject n°1, after adjustment and interpolation, according to BDR and using Darcy softw... by Maryam Fourtassi (434220)

Riociguat prevents hyperoxia-ablated vascular development. by Keyur Donda (5497400)

“…<p>(<b>A</b>) Immunofluorescence staining for von-Willebrand factor (vWF) (green signal). …”

Nerve slices at 10x magnification demonstrating number of micrographs and stereology sample. by Alison L. Wong (11091044)

Image_1_Neonatal subarachnoid hemorrhage disrupts multiple aspects of cerebellar development.TIFF by David F. Butler (15371119)

Intersection between the set of genes within the R1-R4 genomic regions and the sets of genes covered by online cvxNDL dictionary elements for chr2L. by Vishal Rana (18570649)

“…<p>We determined the sizes of the intersections of the set of genes covered by each dictionary element and the genes in the R1-R4 genomic region and arranged them in decreasing order. …”

Table1_Echocardiography-guided percutaneous intramyocardial alginate hydrogel implants for heart failure: canine models with 6-month outcomes.docx by Hui Ma (290168)

“…Compared with controls at 6-month, PIMAHI group significantly increased LVFW thickness (8.5 ± 0.3 vs. 6.8 ± 0.2 mm, p = 0.002) and IVS (7.9 ± 0.1 vs. 6.1 ± 0.2 mm, p < 0.001); decreased LVEDV (30.1 ± 1.6 vs. 38.9 ± 4.5 ml, p = 0.049) and ESV (17.3 ± 1.2 vs. 28.7 ± 3.6 ml, p = 0.004); increased LV systolic function (42.7 ± 1.5 vs. 26.7 ± 1.1% in EF, p = 0.001); and enhanced LV myocardial contractility including GLS (13.5 ± 0.8 vs. 8.4 ± 0.6%, p = 0.002), GCS (16.5 ± 1.4 vs. 9.2 ± 0.6%, p = 0.001), and MAD (11.4 ± 3.5vs 4.6 ± 2.5 mm, p = 0.003). …”

Data Sheet 1_Plausibility of super high-flux dialyzer reuse in maintenance hemodialysis.pdf by Piyapun Prapunwatana (22474063)

“…Dialysate albumin loss decreased significantly from 1.01 g during the 1st use to 0.19 g during the 2nd and 0.06 g during the 5th use (p-value < 0.001). …”

Acquisition of plasmid-mediated cephalosporinase producing <i>Enterobacteriaceae</i> after a travel to the tropics by Florian Lorme (6095348)

“…The carriage of pAmpC-E decreased quickly after return with 92.5% of colonized travelers being negative at one month. …”

Image_4_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

“…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”

Image_3_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

“…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”

Image_1_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

“…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”

Image_2_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

“…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”